Special Investigation (All Case Survey) in Patients With Juvenile Idiopathic Arthritis

Trial Profile

Special Investigation (All Case Survey) in Patients With Juvenile Idiopathic Arthritis

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 02 Aug 2017

At a glance

  • Drugs Adalimumab (Primary)
  • Indications Juvenile rheumatoid arthritis
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Abbott Laboratories; AbbVie
  • Most Recent Events

    • 16 May 2017 Status changed from recruiting to active, no longer recruiting.
    • 01 Aug 2016 Planned primary completion date changed from 1 May 2016 to 1 Jun 2018.
    • 28 Apr 2016 Planned End Date changed from 1 May 2016 to 1 Jun 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top